Skip to main content
. Author manuscript; available in PMC: 2008 Aug 1.
Published in final edited form as: Antiviral Res. 2006 Dec 20;75(2):104–112. doi: 10.1016/j.antiviral.2006.11.013

TABLE 1.

Time course of tissue viral titers in i.p.-inoculated 7-8 week old BALB/c mice.

Days post-viral injection – viral titers (log10 infectious doses/g tissue or mL plasma ± S.D.)

Virus Tissue 1 2 3 4 5 6 7 8 9 10 14
BaV Serum (1/4)a (1/4) (1/4) (3/4) (1/4) (0/4) (2/4) (2/4) (1/4) (1/4) (1/4)
NCb NC NC 3.3 ± 0.8 NC NC 3.7 ± 1.6 6.1 ± 1.6 NC NC NC
BaV Spleen (1/4) (1/4) (1/4) (3/3) (3/4) (2/4) (1/4) (2/4) (3/4) (4/4) (0/4)
NC NC NC 3.6 ± 0.5 4.9 ± 0.6 4.3 ± 0.6 NC 3.4 ± 0.1 3.5 ± 1.2 4.0 ± 0.7 NC
BaV Kidney (0/4) (0/4) (0/4) (3/4) (1/4) (0/4) (2/4) (2/4) (2/4) (3/4) (0/4)
NC NC NC 3.4 ± 0.5 NC NC 2.8 ± 0.7 6.6 ± 4.1 4.0 ± 1.0 3.9 ± 0.8 NC
BaV Liver (0/4) (1/4) (1/4) (2/4) (2/4) (0/4) (0/4) (2/4) (2/4) (3/4) (0/4)
NC NC NC 2.6 ± 0.0 3.2 ± 0.2 NC NC 4.4 ± 2.0 3.8 ± 1.4 4.6 ± 2.2 NC
BaV Brain (0/4) (0/4) (0/4) (1/4) (2/4) (2/4) (1/4) (4/4) 4/4 (4/4) (1/4)
NC NC NC NC 3.6 ± 0.1 3.6 ± 1.4 NC 8.3 ± 0.8 6.7 ± 2.9 7.3 ± 2.0 NC

SFV Serum (4/4) (4/4) (3/4) (0/4) (0/4) (0/4) (0/4) (0/4) (0/4) - (0/4) NC
4.2 ± 0.2 4.7 ± 0.5 2.4 ± 0.8 NC NC NC NC NC NC NC
SFV Spleen (4/4) (4/4) (4/4) (4/4) (2/4) (1/4) (0/4) (0/4) (0/4) - (0/4)
3.6 ± 1.8 4.8 ± 0.9 4.6 ± 0.5 3.9 ± 0.7 2.5 ± 0.2 NC NC NC NC NC
SFV Kidney (4/4) (4/4) (4/4) (2/4) (1/4) (1/4) (0/4) (0/4) (0/4) - (0/4)
3.7 ± 2.1 4.1 ± 1.0 2.7 ± 0.3 2.4 ± 0.2 NC NC NC NC NC NC
SFV Liver (4/4) (4/4) (4/4) (1/4) (0/4) (0/4) (0/4) (0/4) (0/4) - (0/4)
3.3 ± 2.0 4.6 ± 0.8 3.4 ± 0.3 NC NC NC NC NC NC NC
SFV Brain (0/4) (3/4) (4/4) (4/4) (4/4) (4/4) (4/4) (4/4) (4/4) - (0/4)
NC 1.7 ± 1.2 5.2 ± 0.3 6.4 ± 0.9 6.9 ± 1.1 7.5 ± 0.5 6.9 ± 1.4 7.3 ± 0.6 5.8 ± 1.0 NC
a

Number of samples with detectable virus/total animals assayed.

b

NC- Not Calculated. Means were not calculated when most samples were below the limits of detection.